Ark. Couple Says GSK Concealed Risk of Birth Defects Caused by Off-Label Use of Zofran

LITTLE ROCK, Ark. — An Arkansas couple has accused GlaxoSmithKline of fraudulently marketing its anti-nausea drug Zofran as an off-label morning sickness remedy while concealing the risk that ingestion of the drug by pregnant women can cause serious birth defects.

In their May 21 complaint filed in the U.S. District Court for the Eastern District of Texas, Jill Cox and her husband allege that Cox’s ingestion of Zofran during the early stages of her pregnancy caused her son to be born with a birth defect.

Cox was prescribed Zofran to treat her morning sickness. Her son Jacob was born in …